We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Green Plains
GPRE
$1.24B
| $2.75K | ﹤0.01% |
+290
| New | +$3.27K |
|
|
HONE
1427
DELISTED
HarborOne Bancorp
HONE
| $2.72K | ﹤0.01% |
+230
| New | +$2.92K |
|
1428
Ormat Technologies
ORA
$6.38B
| $2.71K | ﹤0.01% |
+40
| New | +$3.09K |
|
1429
Inogen
INGN
$176M
| $2.66K | ﹤0.01% |
+290
| New | +$2.71K |
|
|
UPB
1430
Upstream Bio Inc
UPB
$359M
| $2.63K | ﹤0.01% |
+160
| New | +$3.57K |
|
1431
Nature's Sunshine
NATR
$366M
| $2.62K | ﹤0.01% |
+179
| New | +$2.62K |
|
1432
MACOM Technology Solutions
MTSI
$21.6B
| $2.6K | ﹤0.01% |
+20
| New | +$2.52K |
|
1433
Dorman Products
DORM
$4.03B
| $2.59K | ﹤0.01% |
+20
| New | +$2.56K |
|
1434
Q32 Bio
QTTB
$448M
| $2.58K | ﹤0.01% |
+750
| New | +$23.7K |
|
1435
OR Royalties Inc
OR
$5.53B
| $2.53K | ﹤0.01% |
+140
| New | +$2.72K |
|
|
MRUS
1436
DELISTED
Merus
MRUS
| $2.52K | ﹤0.01% |
+60
| New | +$2.88K |
|
1437
AerSale
ASLE
$288M
| $2.52K | ﹤0.01% |
+400
| New | +$2.29K |
|
|
BCYC
1438
Bicycle Therapeutics
BCYC
$294M
| $2.52K | ﹤0.01% |
+180
| New | +$3.86K |
|
|
PPBI
1439
DELISTED
Pacific Premier Bancorp
PPBI
| $2.49K | ﹤0.01% |
+100
| New | +$2.65K |
|
|
DMN
1440
DELISTED
Damon Inc. Common Stock
DMN
| $2.47K | ﹤0.01% |
+2,910
| New | +$2.85K |
|
1441
Greenfire Resources
GFR
$834M
| $2.4K | ﹤0.01% |
+340
| New | +$2.45K |
|
|
CLYM
1442
Climb Bio
CLYM
$720M
| $2.39K | ﹤0.01% |
+1,330
| New | +$4.81K |
|
1443
Trade Desk
TTD
$8.26B
| $2.35K | ﹤0.01% |
+20
| New | +$2.47K |
|
1444
Smartbird Inc
BIRD
$24.3M
| $2.31K | ﹤0.01% |
+332
| New | +$2.98K |
|
1445
SELLAS Life Sciences
SLS
$2.38B
| $2.29K | ﹤0.01% |
+2,197
| New | +$2.51K |
|
1446
Capital Bancorp
CBNK
$577M
| $2.28K | ﹤0.01% |
+80
| New | +$2.19K |
|
|
ODP
1447
DELISTED
ODP
ODP
| $2.27K | ﹤0.01% |
+100
| New | +$2.78K |
|
|
IGMS
1448
DELISTED
IGM Biosciences
IGMS
| $2.26K | ﹤0.01% |
+370
| New | +$4.4K |
|
1449
Lexicon Pharmaceuticals
LXRX
$999M
| $2.25K | ﹤0.01% |
+3,040
| New | +$3.66K |
|
1450
Zurn Elkay Water Solutions
ZWS
$7.92B
| $2.24K | ﹤0.01% |
+60
| New | +$2.29K |
|
Similar funds
NED
CFG
CFG
WCM
TFP
AFS
EMB
TCPG
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.